These data are supportive of the notion that TCs can trigger ECs to stimulate EC angiogenesis [30,31,32] and also indicate that ALDH1A3 is not only a stem cell marker but also a novel angiogenesis promoter in GBM. The gene discussed is ALDH1A3; the disease is glioblastoma.